NMIH Stock Recent News

The headline numbers for NMI Holdings (NMIH) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

NMI Holdings (NMIH) came out with quarterly earnings of $1.07 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.01 per share a year ago.

EMERYVILLE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (Nasdaq: NMIH) today reported net income of $86.2 million, or $1.07 per diluted share, for the fourth quarter ended December 31, 2024, which compares to $92.8 million, or $1.15 per diluted share, for the third quarter ended September 30, 2024 and $83.4 million, or $1.01 per diluted share, for the fourth quarter ended December 31, 2023. Adjusted net income for the quarter was $86.1 million, or $1.07 per diluted share, which compares to $92.8 million, or $1.15 per diluted share, for the third quarter ended September 30, 2024 and $83.4 million, or $1.01 per diluted share, for the fourth quarter ended December 31, 2023.

EMERYVILLE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its fourth quarter and full year ended December 31, 2024 after the market close on Thursday, February 6, 2025.

NMIH stock is poised to gain from higher new insurance written volume, a comprehensive reinsurance program, financial flexibility and prudent capital deployment.

The 'Undercovered' Dozen series highlights lesser-covered stocks, providing investment ideas and encouraging discussions on their potential. Arcus Biosciences is seen as a "Strong Buy" due to its promising oncology combo therapies and partnerships with Gilead and AstraZeneca. Edmund Ingham sees Sarepta Therapeutics, despite past valuation concerns, as a "Buy" with potential for >50% gain by YE25, driven by Elevidys and ongoing clinical programs.

I recommend National Mortgage Insurance over fintech Upstart due to stark valuation disparities reminiscent of past market bubbles. National Mortgage boasts a 13% earnings yield and a P/E ratio of 7.8, significantly undervalued compared to the S&P 500 and Upstart. The company's strong credit protections and low risk of mortgage defaults make it a safer investment.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

EMERYVILLE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- NMI Holdings, Inc. (NASDAQ: NMIH), the parent company of National Mortgage Insurance Corporation (National MI), today announced that it will report results for its third quarter ended September 30, 2024 after the market close on Wednesday, November 6, 2024.

Investors interested in Insurance - Property and Casualty stocks are likely familiar with NMI Holdings (NMIH) and Chubb (CB). But which of these two stocks is more attractive to value investors?